TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29954932

Group type: EXPERIMENTAL
Intervention: Ixazomib-melphalan-prednisone regimen (ixazomib 4.0 mg [days 1, 8, 15] plus melphalan-prednisone 60 mg/m)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Single-agent ixazomib maintenance
Number of subjects: 61
Study: 29955380

Group type: COMPARATOR
Intervention: TCZ-intravenous
Number of subjects: 3

Group type: COMPARATOR
Intervention: TCZ-subcutaneous
Number of subjects: 3
Study: 29955381

Group type: EXPERIMENTAL
Intervention: Adalimumab monotherapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Methotrexate use
Number of subjects: 140
Study: 29955680

Group type: EXPERIMENTAL
Intervention: Prevention Program for Improving Nutritional Quality of Food Purchases
Number of subjects: 0
Study: 29955682

Group type: EXPERIMENTAL
Intervention: Complementary legume foods, specific types not mentioned, duration not specified.
Number of subjects: 0
Study: 29955692

Group type: EXPERIMENTAL
Intervention: Ad Libitum Carbohydrate and Fat Intake
Number of subjects: 0
Study: 29955695

Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise
Number of subjects: 0
Study: 29955700

Group type: EXPERIMENTAL
Intervention: Fortified blended foods (FBFs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative commodities (sorghum and cowpea)
Number of subjects: 0
Study: 29955707

Group type: EXPERIMENTAL
Intervention: Combined Carbohydrate and Essential Amino Acid Supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-Nutritive Placebo
Number of subjects: 0
Study: 29955710

Group type: EXPERIMENTAL
Intervention: Daily Ethanol Consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 29955713

Group type: EXPERIMENTAL
Intervention: Emulsified Medium-Chain Triglycerides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-emulsified Medium-Chain Triglycerides
Number of subjects: 0
Study: 29955720

Group type: EXPERIMENTAL
Intervention: Almond consumption intervention
Number of subjects: 0
Study: 29955731

Group type: EXPERIMENTAL
Intervention: High-Protein, High-Fiber (HP/HFb) beverage preload
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isocaloric Lower-Protein, Lower-Fiber (LP/LFb) placebo beverage
Number of subjects: 50
Study: 29955789

Group type: EXPERIMENTAL
Intervention: P4 levels 60-100 nmol/l in early luteal phase
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: P4 levels >400 nmol/l in early luteal phase
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: P4 levels 150-250 nmol/l in mid-luteal phase
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: P4 levels >400 nmol/l in mid-luteal phase
Number of subjects: 602
Study: 29955792

Group type: EXPERIMENTAL
Intervention: Tucatinib 300 mg administered orally twice per day for 21 days and T-DM1 3.6 mg/kg administered intravenously once every 21 days.
Number of subjects: 57

Group type: COMPARATOR
Intervention: T-DM1
Number of subjects: 57
Study: 29955793

Group type: EXPERIMENTAL
Intervention: Temozolomide plus radiotherapy
Number of subjects: 129
Study: 29955836

Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine
Number of subjects: 0
Study: 29955837

Group type: EXPERIMENTAL
Intervention: Heterozygous carriers for hereditary fructose intolerance (hHFI)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 8
Study: 29955838

Group type: EXPERIMENTAL
Intervention: Higher spermidine intake
Number of subjects: 829
Study: 29957147

Group type: EXPERIMENTAL
Intervention: Five-repetition sit-to-stand (5R-STS) test
Number of subjects: 157
Study: 29957229

Group type: EXPERIMENTAL
Intervention: Subjects with HFpEF
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 58
Study: 29957715

Group type: EXPERIMENTAL
Intervention: Intervention Phase I (focused education program and implementation of treatment bundle)
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Intervention Phase II (provision of resources to implement treatment bundle)
Number of subjects: 1594

Group type: COMPARATOR
Intervention: Pre-intervention
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Intervention I
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Intervention II
Number of subjects: 1594
Study: 29958217

Group type: EXPERIMENTAL
Intervention: Continuous capnography monitoring after cesarean delivery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nurse observations of respiratory rate (RR)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Capnography device usage
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 80
Study: 29958223

Group type: EXPERIMENTAL
Intervention: STOP-Bang score of <2
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: STOP-Bang score of ≥6
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: STOP-Bang score of 6
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: STOP-Bang and pulse oximetry
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Nightly pulse oximetry
Number of subjects: 449
Study: 29958797

Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy (IST) in severe AA patients
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Non-responding severe AA patients
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: MDS patients
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 58
Study: 29958815

Group type: EXPERIMENTAL
Intervention: EHR-embedded brief geriatric oncology assessment
Number of subjects: 44
Study: 29959612

Group type: EXPERIMENTAL
Intervention: Robotic nipple-sparing mastectomy with immediate prosthetic breast reconstruction (RNSM with IPBR)
Number of subjects: 33
Study: 29959653

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) high frequency (50 Hz)/short duration (180 s)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) high frequency/long duration (360 s)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) low frequency (30 Hz)/short duration
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) low frequency/long duration
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham electrical stimulation (control)
Number of subjects: 35
Study: 29959809

Group type: EXPERIMENTAL
Intervention: Ceritinib (750 mg/day fasted)
Number of subjects: 20
Study: 29959847

Group type: EXPERIMENTAL
Intervention: ThedaCare NRS
Number of subjects: 594

Group type: COMPARATOR
Intervention: NRS 2002
Number of subjects: 594
Study: 29960116

Group type: EXPERIMENTAL
Intervention: Low-zinc group (zinc level <71 μg/dl)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Normal-zinc group (zinc level ≥71 μg/dl)
Number of subjects: 108
Study: 29960588

Group type: EXPERIMENTAL
Intervention: Epicardial adipose tissue (EAT) thickness measurement
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Left ventricular (LV) mass index measurement
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Myocardial function measurement (e' and GLS)
Number of subjects: 140
Study: 29960692

Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Combination of medication and CBT
Number of subjects: 319

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Acute treatment response
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Treatment type
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 319
Study: 29960701

Group type: EXPERIMENTAL
Intervention: Autologous stem cell ovarian transplant (ASCOT)
Number of subjects: 17
Study: 29960809

Group type: EXPERIMENTAL
Intervention: Vegetarian dietary patterns
Number of subjects: 664
Study: 29960985

Group type: EXPERIMENTAL
Intervention: Higher levels of plasma 8-oxo-2'-dG
Number of subjects: 3766

Group type: EXPERIMENTAL
Intervention: Plasma 8-oxo-2'-dG levels
Number of subjects: 3766
Study: 29960990

Group type: EXPERIMENTAL
Intervention: ECF excess defined as ECW/TBW ≥0.390 or ≥0.400 depending on severity.
Number of subjects: 1741

Group type: EXPERIMENTAL
Intervention: ECW/TBW measured using bioelectrical impedance analysis.
Number of subjects: 1741
Study: 29960997

Group type: EXPERIMENTAL
Intervention: Quality of Life assessment using VSP-A and Kidscreen 10
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Children's perspective on QoL
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Parents' perspective on QoL
Number of subjects: 302
Study: 29961004

Group type: EXPERIMENTAL
Intervention: CBM-App (cognitive bias modification-appraisals)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham-training control condition (peripheral vision task)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CBM-App
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham-training control condition
Number of subjects: 80
Study: 29961015

Group type: EXPERIMENTAL
Intervention: Opioid-free anaesthesia (OFA)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard anaesthesia protocol
Number of subjects: 400
Study: 29961023

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) using a tapered flow resistive loading device (POWERbreathe KH2, HaB International, UK), four sets of 6-10 breaths daily against an external load, adjusted to the highest tolerable load.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham-IMT (control group) training against a low resistance that will not be modified during the training period.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 90
Study: 29961037

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 50 Allergan Units of botulinum toxin A (BTA) resuspended in 1 mL saline + splinting
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline injection (1 mL) + splinting
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 50 Allergan Units of BTA + splinting
Number of subjects: 60
Study: 29961039

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed group (DEL)
Number of subjects: 30
Study: 29961213

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide (HP) gel
Number of subjects: 31

Group type: COMPARATOR
Intervention: 35% hydrogen peroxide (HP) gel (control)
Number of subjects: 31
Study: 29961246

Group type: EXPERIMENTAL
Intervention: NPH insulin 0.3 U/kg (high dose corticosteroids group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NPH insulin 0.15 U/kg (low dose corticosteroids group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study: 29961351

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no aerobic exercise training)
Number of subjects: 0
Study: 29961557

Group type: EXPERIMENTAL
Intervention: Direct costs per patient during follow-up
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Cost drivers associated with therapies received
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Hospitalization/emergency costs
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Monthly direct costs per patient during distant metastasis/terminal illness phase
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Monthly direct costs per patient during adjuvant treatment period
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Estimated mean total indirect costs per patient
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Annual national direct cost
Number of subjects: 831
Study: 29961808

Group type: EXPERIMENTAL
Intervention: Zero-time Exercise (ZTEx) intervention
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Community participants
Number of subjects: 28
Study: 29961841

Group type: EXPERIMENTAL
Intervention: Xpert-PoC testing at birth
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Xpert-DBS testing at birth
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Xpert testing by week 3
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Xpert-PoC testing at week 6
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Xpert-PoC tests overall
Number of subjects: 614
Study: 29962529

Group type: EXPERIMENTAL
Intervention: 40 mg of IV parecoxib
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 29962926

Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg single oral dose for 3 days, then 25 mg QD for 5 days, and 12.5 mg QD for another 3 days
Number of subjects: 3
Study: 29963053

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow-derived mesenchymal stromal cells (MSCs) given at day 7 posttransplant
Number of subjects: 4
Study: 29964145

Group type: EXPERIMENTAL
Intervention: In-person consultation at public events (e.g., basketball game, county fair)
Number of subjects: 2185

Group type: EXPERIMENTAL
Intervention: Online consultation via multimedia direction to an online website and social media advertising
Number of subjects: 2185

Group type: EXPERIMENTAL
Intervention: Mail consultation
Number of subjects: 2185

Group type: COMPARATOR
Intervention: Print advertisements in local papers
Number of subjects: 2185
Study: 29965865

Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 72
Study: 29966429

Group type: COMPARATOR
Intervention: Resting heart rate of 70-79 bpm in men
Number of subjects: 233970

Group type: COMPARATOR
Intervention: Resting heart rate of 80-89 bpm in women
Number of subjects: 233970

Group type: COMPARATOR
Intervention: Resting heart rate >90 bpm
Number of subjects: 233970
Study: 29966800

Group type: EXPERIMENTAL
Intervention: Crizotinib 250 mg orally twice daily continuously (3-week cycles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy (pemetrexed 500 mg/m2 intravenously)
Number of subjects: 0
Study: 29966863

Group type: EXPERIMENTAL
Intervention: Lobaplatin 25-50 mg/m² concurrent with IMRT
Number of subjects: 17
Study: 29967236

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study: 29967357

Group type: EXPERIMENTAL
Intervention: Jackhammer esophagus (JE) diagnosis
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: GERD positive diagnosis
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Acid hypersensitive esophagus diagnosis
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Clinical parameters differentiation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Prevalence of JE
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: True GERD diagnosis
Number of subjects: 37
Study: 29967588

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 29967693

Group type: EXPERIMENTAL
Intervention: Schizophrenia Coping Oral Health Profile (SCOOHP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SCOOHP scale with 23 items (15 items for positive coping and 8 items for negative coping)
Number of subjects: 20
Study: 29968240

Group type: EXPERIMENTAL
Intervention: Surgery combined with radiation (ART group)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Surgery alone (NORT group)
Number of subjects: 178
Study: 29968431

Group type: EXPERIMENTAL
Intervention: Atorvastatin plus pioglitazone (30 mg/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 41
Study: 29968437

Group type: EXPERIMENTAL
Intervention: DASH and home-based exercise group (D+Ex)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Advice-only comparison group (C)
Number of subjects: 85
Study: 29968501

Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Bypass grafting
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Femoral artery patchplasty
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Endovascular revascularization
Number of subjects: 1200
Study: 29969456

Group type: EXPERIMENTAL
Intervention: Higher-taxed sugary soft drinks
Number of subjects: 2836

Group type: EXPERIMENTAL
Intervention: Lower-taxed soft drinks
Number of subjects: 2836

Group type: EXPERIMENTAL
Intervention: Sugary soft drinks
Number of subjects: 2836

Group type: EXPERIMENTAL
Intervention: Overall impact of the tax
Number of subjects: 2836

Group type: EXPERIMENTAL
Intervention: Subgroup analyses
Number of subjects: 2836
Study: 29969586

Group type: EXPERIMENTAL
Intervention: Depressed women
Number of subjects: 732
Study: 29969916

Group type: EXPERIMENTAL
Intervention: 10-step simplified Tai-chi training programme for 16 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Recreational activities organized by the centres
Number of subjects: 26
Study: 29969990

Group type: EXPERIMENTAL
Intervention: ACQUIRE-ICD care innovation (comprehensive interactive eHealth intervention)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 478
Study: 29969998

Group type: EXPERIMENTAL
Intervention: Echocardiography screening conducted by trained local radiographers
Number of subjects: 1102
Study: 29970005

Group type: EXPERIMENTAL
Intervention: Systematic medication review based on the RASP list
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 59
Study: 29970046

Group type: EXPERIMENTAL
Intervention: Training provided to increase moderate-to-vigorous physical activity (MVPA) during the program by extending scheduled time for activity opportunities and modifying games.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Programs that gained MVPA (avg. +5.5 to +10.1 min MVPA) modified their program in supportive ways.
Number of subjects: 20
Study: 29970050

Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during school hours
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during weekdays
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during weekend days
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during afternoon hours
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during total leisure time
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring over a 7-day week
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Monitoring period for achieving reliability of 0.80 across all domains
Number of subjects: 676
Study: 29970063

Group type: EXPERIMENTAL
Intervention: Self-collected HPV tests during community health campaign
Number of subjects: 255
Study: 29970107

Group type: EXPERIMENTAL
Intervention: Vocational Rehabilitation Programme (VRP)
Number of subjects: 0
Study: 29970108

Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 0
Study: 29970172

Group type: EXPERIMENTAL
Intervention: SQUEAC conjugate Bayesian analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-stage cluster survey
Number of subjects: 0
Study: 29970319

Group type: EXPERIMENTAL
Intervention: 750 mg of soy-derived phosphatidic acid (PA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Rice-flour placebo (PL)
Number of subjects: 16
Study: 29970357

Group type: EXPERIMENTAL
Intervention: Mobile phone delivered intervention based on Acceptance and Commitment Therapy (ACT)
Number of subjects: 251
Study: 29970389

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections on days 0, 30, 60, and 90, plus hyaluronic acid five times per day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid five times per day
Number of subjects: 30
Study: 29971158

Group type: EXPERIMENTAL
Intervention: 67% sodium bicarbonate dentifrice
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 56
Study: 29971569

Group type: EXPERIMENTAL
Intervention: Self-rated apathy scores
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Informant-rated apathy scores
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Self-rated depression scores
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Informant-rated depression scores
Number of subjects: 35
Study: 29971962

Group type: COMPARATOR
Intervention: Bioelectrical impedance analysis (BIA) measuring Phase Angle (PA) and levels of extra-/intracellular water (ECW; ICW)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bioelectrical impedance analysis (BIA) measuring ICW levels
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) measuring correlation between PA and ICW
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) measuring ECW/ICW ratio
Number of subjects: 38
Study: 29972089

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100[200]/25 µg
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/Salm)
Number of subjects: 1264
Study: 29972716

Group type: EXPERIMENTAL
Intervention: ASP8273 300 mg
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: ASP8273
Number of subjects: 121
Study: 29972871

Group type: EXPERIMENTAL
Intervention: rhPTH(1-84)
Number of subjects: 13
Study: 29973147

Group type: EXPERIMENTAL
Intervention: Costs in the highest quintile by country and index event diagnosis
Number of subjects: 12922

Group type: EXPERIMENTAL
Intervention: Mean length of stay
Number of subjects: 12922

Group type: EXPERIMENTAL
Intervention: Highest-cost countries
Number of subjects: 12922
Study: 29973153

Group type: EXPERIMENTAL
Intervention: Phenylbutyrate (PBA) 500mg twice daily for 8 weeks
Number of subjects: 31
Study: 29973204

Group type: EXPERIMENTAL
Intervention: Ipilimumab (10 mg/kg IV every 3 weeks for 2 doses)
Number of subjects: 0
Study: 29973227

Group type: EXPERIMENTAL
Intervention: Pegvaliase treatment
Number of subjects: 68
Study: 29973233

Group type: EXPERIMENTAL
Intervention: Tubular cellular injury (induced by ischemia-reperfusion injury)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mouse model of kidney warm ischemia-reperfusion injury
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clinical study subjects post tubular cell injury
Number of subjects: 20